SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-18-008670
Filing Date
2018-02-14
Accepted
2018-02-14 13:58:26
Documents
1
Group Members
DR. ANAND MEHRADR. JAMES I. HEALYDR. MICHAEL F. POWELLSOFINNOVA MANAGEMENT VIII, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv485877_sc13da.htm SC 13D/A 90949
  Complete submission text file 0001144204-18-008670.txt   92587
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners VIII, L.P. (Filed by) CIK: 0001524064 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89137 | Film No.: 18610679
SIC: 2834 Pharmaceutical Preparations